CDK4 and lung adenocarcinoma: The mechanism was revealed to inhibit CDK4/CDK6-cyclinD1 complex by increasing p21 expression in colorectal cells, and upregulate p21 expression level in lung adenocarcinoma cells (Li et al., 2014b; Zhao et al., 2016).